|
Volumn 349, Issue 15, 2003, Pages 1476-1479
|
High-dose chemotherapy for breast cancer [1] (multiple letters)
a a a b b b c d d e e f g h i j
d
City Hospital
(Italy)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FLUOROURACIL;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG MEGADOSE;
FEMALE;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
META ANALYSIS;
ONCOLOGY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
BREAST TUMOR;
LABORATORY DIAGNOSIS;
LYMPH NODE METASTASIS;
NOTE;
STATISTICAL ANALYSIS;
TUMOR RECURRENCE;
ADJUVANT CHEMOTHERAPY;
SURVIVAL;
TIME;
METASTASIS;
DISEASE FREE SURVIVAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
DATA INTERPRETATION, STATISTICAL;
FALSE POSITIVE REACTIONS;
HUMANS;
LYMPHATIC METASTASIS;
META-ANALYSIS;
NEOPLASM RECURRENCE, LOCAL;
CHEMOTHERAPY, ADJUVANT;
SURVIVAL ANALYSIS;
TIME FACTORS;
DISEASE-FREE SURVIVAL;
FEMALE;
|
EID: 0141863484
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200310093491515 Document Type: Letter |
Times cited : (1)
|
References (0)
|